Dr. Jason David Goldman, MD, MPH

Dr. Goldman practices at UW Medical Center - Northwest in Seattle, Washington.

Dr. Goldman's NPI, 1740436609, was assigned on August 12, 2008. Dr. Goldman graduated from Perelman School of Med at the University of Pennsylvania in 2008. Dr. Goldman holds Washington license MD60232633.

Dr. Goldman's primary practice is UW Medical Center - Northwest, at 1550 N 115th St, Seattle, WA 98133 in King County. The practice phone is (206) 364-0500.

Dr. Goldman's primary practice is UW Medical Center - Northwest in Seattle, Washington. Dr. Goldman is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Goldman to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldman practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Goldman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Goldman is licensed in Washington.

CMS data shows 248 Medicare services from Dr. Goldman across 5 procedure codes in 2024, for 141 Medicare patients. Medicare paid $25,098 for them.

CMS counts 141 Medicare patients who saw Dr. Goldman in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goldman's median patient age at 67, with 43% women.

In 2024, Dr. Goldman wrote 437 Medicare Part D claims for 65 patients. 46% of them were for generic drugs. CMS names the drug for 266 of them, across 11 drugs with 11 or more claims each, at $681,070 in total drug cost. In 2023, CMS named 268 claims across 13 drugs.

Dr. Goldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goldman as offering telehealth.

Dmand AI links 65 papers to Dr. Goldman, published from 2012 to 2025. 2020 was the busiest year, with 10. The most frequent topics are SARS-CoV-2, COVID-19 and COVID-19 Drug Treatment. Dr. Goldman has published most often in Clin Infect Dis. Dr. Goldman's most frequent co-authors are Cynthia Elaine Fisher, MD, Ricardo Martin La Hoz, MD and Grace A. McComsey, MD.

Dmand AI links Dr. Goldman to 3 clinical trials. 1 is still active or recruiting. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 50 general payments to Dr. Goldman from 5 drug and device companies from 2017 to 2024. Speaker and faculty fees make up the largest share, 52% of the total. Gilead Sciences, Inc. paid the most, $39,390. It also lists 1 research payment totaling $29,620 in 2017.

Dr. Goldman graduated from Perelman School of Med at the University of Pennsylvania in 2008.